This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Adverse event reporting can be found at the bottom of the page
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Menu
Close
Example of description text sitting alongside header
Example of description text sitting alongside header
Click here for VYNDAQEL®▼ (tafamidis) Prescribing Information.
Please find below case study service examples from across the UK. The summary videos and interactive PDFs illustrate how amyloidosis services have adapted in order to manage the increasing demands on capacity1 and the diagnostic delay. These materials are intended to support UK Healthcare Professionals.
Leeds General Infirmary
A proactive approach to ATTR-CM Management
Models of Care: Leeds Infographic
A digital infographic developed & funded by Pfizer and
co-created with the Leeds General Infirmary team, designed to act as a best practice example of a proactive approach to patient management in ATTR-CM.
Models of Care: Leeds Video
This is a video developed & funded by Pfizer and co-created with the Leeds General Infirmary team, designed to act as a best practice example of a proactive approach to patient management in ATTR-CM.
University Hospitals Birmingham
Midlands Amyloidosis Service (MAS)
Models of Care: Birmingham Infographic
A digital infographic developed & funded by Pfizer and co-created with Dr Will Moody from Queen Elizabeth Hospital Birmingham, designed to act as a best practice example of developing a regional amyloidosis service.
Models of Care: Birmingham Video
This is a video developed & funded by Pfizer and co-created with Dr Will Moody from Queen Elizabeth Hospital Birmingham, designed to act as a best practice example of developing a regional amyloidosis service.
Learn more about the pathogenesis of ATTR-CM and how VYNDAQEL works
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2024 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-UNP-GBR-7812. January 2024